[Tech News] Thought-controlled bionic arm restores touch in first home trial: inside the Utah neuroprosthetic breakthrough

He controls it with his thoughts — and he can feel with it too

Alexander "Avi" Davidson, 33, of Tampa, Florida, just became the first person in the world to take home a thought-controlled bionic arm that restores the sense of touch. As the inaugural participant in a first-of-its-kind clinical trial at the University of Utah, Davidson is now using the neuroprosthetic in everyday life — writing, playing cards, making a tuna sandwich, and, in his words, the thing that matters most: holding his wife's hand and feeling her hand in return.

The trial will follow him for a full year, offering the first real-world test of whether nerve-connected prosthetics can genuinely transform daily life for people with limb loss.

From a 35-foot fall to a Luke Skywalker arm

At 16, Davidson fell 35 feet from the top of a telephone pole. The accident left him paralyzed from the waist down and led to the amputation of his left arm below the elbow. Seventeen years later, he's testing technology its developers openly describe as inspired by Luke Skywalker's robotic hand.

The system pairs a prosthetic built on DEKA's commercially available LUKE Arm platform with a direct nerve interface called the BIOS Controller, developed at the Utah NeuroRobotics Lab. The interface reads neural signals to translate Davidson's thoughts into movement — and simultaneously sends touch sensations back to his brain, so the hand feels, in his words, "so authentic."

"The ability to have a return of sensation to my previously dominant hand is a life-altering experience, as I never imagined feeling any part of that hand in my lifetime," Davidson said. "The ability to recognize how much pressure I'm putting on my wife's hand and to feel hers back in mine is a wild idea to internalize."

Why "at home" is the breakthrough

Eight previous participants tested versions of the technology — but only under supervision in University of Utah labs. Davidson is the first to use it independently at home, unsupervised, for an extended period. That leap was enabled by advances in AI and software that make the sensation more lifelike and the control more intuitive outside controlled conditions.

It matters because lab demos and daily life are different planets. A prosthetic that works on a test bench but fails while cooking dinner isn't independence. A year of real-world data — cooking, dressing, working, living — will show whether nerve-connected prosthetics are ready to leave the lab for good. Davidson is documenting the journey publicly as he goes.

The road to real patients

The BIOS interface received the FDA's Breakthrough Devices Program designation back in March 2024, a status meant to speed review of technologies for serious conditions. But "breakthrough" doesn't mean "available": the trial runs a year with a possible extension, and commercial availability — plus the question of who pays — remains years away.

Still, the trajectory is unmistakable. Direct nerve interfaces are moving from science fiction to clinical reality, and each trial participant generates the safety and efficacy data regulators need. For the millions worldwide living with limb loss, Davidson's year at home is the most important test yet.

What the year-long trial will measure

Researchers aren't just checking whether the arm works — they're studying whether it changes Davidson's daily life in measurable ways. Over the coming year, the team will track how often he chooses the bionic arm over other tools, which tasks become easier, and whether restored sensation reduces the mental effort of everyday actions. That kind of longitudinal, at-home data has never existed for nerve-connected prosthetics, and it's exactly what regulators and insurers will demand before this technology reaches more patients.

The bottom line

Seventeen years after losing his arm, Avi Davidson can feel his wife's hand in his again — not through a screen or a simulation, but through a bionic hand his own thoughts control. If the next twelve months go well, he won't be the last.

Disclosure: This post contains affiliate links. If you buy through them, I may earn a commission at no extra cost to you.